Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR1 | P30556 | 8/20 | 0.40 |
| ▸ | AGTR2 | P50052 | 5/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | PPARG | P37231 | 2/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9708632 | 0.97 | AGTR1 (0.40) | AGTR1AGTR2KMT2APPARGADORA3 | |
| SCHEMBL9707900 | 0.94 | AGTR1 (0.43) | AGTR1AGTR2KMT2APPARGADORA3 | |
| SCHEMBL9708144 | 0.92 | AGTR1 (0.43) | AGTR1AGTR2KMT2APPARG | |
| SCHEMBL9708108 | 0.92 | AGTR1 (0.44) | AGTR1AGTR2KMT2APPARGADORA3 | |
| SCHEMBL9708158 | 0.91 | ADORA3 (0.41) | AGTR1AGTR2ADORA3ADORA1 | |
| SCHEMBL9707631 | 0.91 | AGTR1 (0.40) | AGTR1AGTR2KMT2APPARGMEN1 | |
| SCHEMBL9707639 | 0.91 | AGTR1 (0.40) | AGTR1AGTR2KMT2APPARGADORA3 | |
| SCHEMBL9707542 | 0.91 | AGTR1 (0.43) | AGTR1AGTR2KMT2APPARG | |
| SCHEMBL9707449 | 0.90 | KMT2A (0.45) | AGTR1AGTR2KMT2AMEN1CYP2C9 | |
| SCHEMBL9707832 | 0.90 | AGTR1 (0.52) | AGTR1AGTR2PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1992007852-A1 | BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1992-05-14 | — | — | WO | disclosed |